Cholesterol: It’s the double-edged sword of our biology. While high levels are notorious for fueling heart disease and stroke, this fatty molecule is also essential, quietly orchestrating processes in every cell of our body—many of which science still doesn’t fully understand. But here’s where it gets fascinating: What if we could control cholesterol’s activity like flipping a light switch? Scientists have just done exactly that.
In a groundbreaking study published in the Journal of the American Chemical Society, researchers led by Michael Zott and Dirk Trauner at the University of Pennsylvania have engineered light-controlled versions of cholesterol, dubbed ‘photocholesterols.’ These molecules change shape when exposed to light, allowing scientists to toggle their biological activity on or off with precision. And this is the part most people miss: this innovation could revolutionize how we treat diseases by activating drugs deep within the body using light—a method far more precise than traditional approaches.
Cholesterol’s dual nature makes it a tricky molecule to study. While it’s vital for building cell membranes and producing hormones like estrone and testosterone, its tiny size and elusive behavior have long challenged researchers. ‘Studying cholesterol is like trying to track a shadow—it’s everywhere yet hard to pin down,’ explains Zott, a Beckman Postdoctoral Fellow. To overcome this, scientists often use ‘functional derivatives’—molecules that mimic cholesterol but include chemical tags for easier tracking.
The new photocholesterols take this a step further. By attaching light-sensitive compounds, the team can manipulate cholesterol’s activity in real time. ‘Using light gives us spatiotemporal control,’ says Trauner, co-senior author of the paper. ‘Imagine taking a medication and then activating it precisely where and when it’s needed—like shining a flashlight on a specific organ.’ This approach could transform therapies for conditions where traditional drugs fall short.
But here’s where it gets controversial: Not all photocholesterols behaved as expected. Instead of a one-size-fits-all solution, some showed a strong preference for certain transport proteins, leading to an unexpected discovery. One molecule emerged as a selective inhibitor of ORP1 and ORP2—two sterol transport proteins whose roles in cholesterol balance remain poorly understood. ‘This is a game-changer,’ says co-senior author Luca Laraia of the Technical University of Denmark. ‘We now have tools to unravel the mysteries of these proteins, potentially leading to new therapies.’
The team’s future plans are equally ambitious. They aim to map cholesterol’s movement within cells under normal and disease-like conditions using light precision. Additionally, they’re adapting this strategy to create light-controlled versions of other lipids, with long-term goals including light-activated mRNA delivery and systemic therapies that can be locally activated. ‘Cholesterol is at the heart of biology,’ Zott notes. ‘By controlling it with light, we’re not just studying it—we’re unlocking new ways to improve health.’
Thought-provoking question for you: If we can control cholesterol’s activity with light, what other biological processes might we one day manipulate? Could this lead to ethical dilemmas in medicine or biotechnology? Share your thoughts in the comments—let’s spark a conversation!
